{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:31:32Z","timestamp":1767832292392,"version":"3.49.0"},"reference-count":29,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,10,5]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>To date, no specific antivirus drugs or vaccines have been available to prevent or treat the COVID-19 pandemic. Mesenchymal stem cell (MSC) therapy may be a promising therapeutic approach that reduces the high mortality in critical cases. This protocol is proposed for a systematic review and meta-analysis that aims to evaluate the efficacy and safety of MSC therapy on patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Ten databases including PubMed, EMBASE, Cochrane Library, CINAHL, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), Wanfang database, China Biomedical Literature Database (CBM) and Chinese Biomedical Literature Service System (SinoMed) will be searched from inception to 1 December 2020. All published randomised controlled trials, clinical controlled trials and case series that meet the prespecified eligibility criteria will be included. The primary outcomes include mortality, incidence and severity of adverse events, respiratory improvement, days from ventilator, duration of fever, progression rate from mild or moderate to severe, improvement of such serious symptoms as difficulty breathing or shortness of breath, chest pain or pressure, and loss of speech or movement, biomarkers of laboratory examination and changes in CT. The secondary outcomes include dexamethasone doses and quality of life. Two reviewers will independently perform study selection, data extraction and assessment of bias risk. Data synthesis will be conducted using RevMan software (V.5.3.5). If necessary, subgroup and sensitivity analysis will be performed. Grading of Recommendations Assessment, Development and Evaluation system will be used to assess the strength of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval is not necessary since no individual patient or privacy data have been collected. The results of this review will be disseminated in a peer-reviewed journal or an academic conference presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42020190079.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-042085","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T18:20:21Z","timestamp":1608661221000},"page":"e042085","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of mesenchymal stem cells for the treatment of patients infected with COVID-19: a systematic review and meta-analysis protocol"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-8018","authenticated-orcid":false,"given":"Yunhui","family":"Chen","sequence":"first","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"You","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglong","family":"Liu","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songqi","family":"Tang","sequence":"additional","affiliation":[{"name":"Hainan Medical University, Haikou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiane","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"2025121523531401000_10.12.e042085.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)302518"},{"key":"2025121523531401000_10.12.e042085.2","unstructured":"World Health Organization . Rolling updates on coronavirus disease (COVID-19), 2020. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen"},{"key":"2025121523531401000_10.12.e042085.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2025121523531401000_10.12.e042085.4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121523531401000_10.12.e042085.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004500"},{"key":"2025121523531401000_10.12.e042085.6","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet"},{"key":"2025121523531401000_10.12.e042085.7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12015-018-9866-1","article-title":"Biological products: cellular therapy and FDA Approved products","volume":"15","author":"Golchin","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"2025121523531401000_10.12.e042085.8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1574888X13666180913123424","article-title":"The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and Concise review","volume":"14","author":"Golchin","year":"2019","journal-title":"Curr Stem Cell Res Ther"},{"key":"2025121523531401000_10.12.e042085.9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (start study): a randomised phase 2A safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025121523531401000_10.12.e042085.10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.eng.2020.02.006","article-title":"Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment","volume":"6","author":"Chen","year":"2020","journal-title":"Engineering"},{"key":"2025121523531401000_10.12.e042085.11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/ped.14001","article-title":"Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia","volume":"61","author":"Namba","year":"2019","journal-title":"Pediatr Int"},{"key":"2025121523531401000_10.12.e042085.12","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-020-1034-8","article-title":"Emerging therapeutic potential of mesenchymal stem\/stromal cells in preeclampsia","volume":"22","author":"Suvakov","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"2025121523531401000_10.12.e042085.13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021429","article-title":"Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report","volume":"99","author":"Liang","year":"2020","journal-title":"Medicine"},{"key":"2025121523531401000_10.12.e042085.14","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0228"},{"key":"2025121523531401000_10.12.e042085.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"2025121523531401000_10.12.e042085.16","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025121523531401000_10.12.e042085.17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13287-020-01612-y","article-title":"Mesenchymal stem cells regulate the Th17\/Treg cell balance partly through hepatocyte growth factor in vitro","volume":"11","author":"Chen","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"2025121523531401000_10.12.e042085.18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-019-1307-9","article-title":"Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer","volume":"10","author":"Luz-Crawford","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"2025121523531401000_10.12.e042085.19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/cmi.2016.59","article-title":"Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner","volume":"14","author":"Cho","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"2025121523531401000_10.12.e042085.20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells","volume":"36","author":"de Witte","year":"2018","journal-title":"Stem Cells"},{"key":"2025121523531401000_10.12.e042085.21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02538","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function","volume":"9","author":"Reis","year":"2018","journal-title":"Front Immunol"},{"key":"2025121523531401000_10.12.e042085.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0023-5"},{"key":"2025121523531401000_10.12.e042085.23","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12815"},{"key":"2025121523531401000_10.12.e042085.24","doi-asserted-by":"publisher","DOI":"10.1002\/stem.544"},{"key":"2025121523531401000_10.12.e042085.25","doi-asserted-by":"crossref","DOI":"10.1016\/j.btre.2020.e00467","article-title":"Combating COVID-19 with mesenchymal stem cell therapy","volume":"26","author":"Rajarshi","year":"2020","journal-title":"Biotechnol Rep"},{"key":"2025121523531401000_10.12.e042085.26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020781","article-title":"Efficacy of integrative traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a protocol for systematic review and meta analysis","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine"},{"key":"2025121523531401000_10.12.e042085.27","unstructured":"Chandler J , Higgins JPT , Deeks JJ . Cochrane handbook for systematic reviews of interventions version 5.2.0: cochrane community. 2nd Edition. Chichester (UK: John Wiley & Sons, 2019."},{"key":"2025121523531401000_10.12.e042085.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"2025121523531401000_10.12.e042085.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.011"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-042085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:53:23Z","timestamp":1765871603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-042085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,18]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bmjopen-2020-042085"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-042085","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}